OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia
Clinical trial NCT06136390 · COMPLETED
Trial details
- NCT number
- NCT06136390
- Sponsor
- Charite University, Berlin, Germany
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-30
- Primary completion
- 2024-12-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.